Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lill-Tove Busund
The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort
Oncotarget
Oncology
MicroRNA 141 Is Associated to Outcome and Aggressive Tumor Characteristics in Prostate Cancer
Scientific Reports
Multidisciplinary
Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated With Ang-2
PLoS ONE
Multidisciplinary
Related publications
New Developments in the Diagnosis and Treatment of Thyroid Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
No Cost or Safety Advantage to Robot-Assisted Radical Prostatectomy Compared With Open-Procedure Surgery for Patients With Prostate Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Challenges in Ductal Carcinoma in Situ Risk Communication and Decision-Making
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Risk Factors, Pathophysiology, and Treatment of Hot Flashes in Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Angiogenesis Inhibitors: Current Strategies and Future Prospects
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Population-Based Programs for Increasing Colorectal Cancer Screening in the United States
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Treatment and Survivorship Statistics, 2019
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Germline Mutations in Pancreatic Cancer Become Better Defined
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening
CA - A Cancer Journal for Clinicians
Oncology
Hematology
